FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 1020967 · Received March 26, 2008

Report

Report Number
9616099-2008-00714
Event Type
Injury
Date Received
March 26, 2008
Date of Event
February 2, 2006
Report Date
March 24, 2006
Manufacturer
CORDIS DE MEXICO
Product Code
NIQ
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE (LOT I0405107) IS DISTRIBUTED OUTSIDE THE UNITED STATES; HOWEVER, IT IS SIMILAR TO THE UNITED STATES PRODUCT. THE PRODUCT REMAINS IMPLANTED IN THE PT AND IS NOT AVAILABLE FOR ANALYSIS. ADD'L INFO WILL BE SUBMITTED WITHIN THIRTY DAYS UPON RECEIPT.

Description of Event or Problem · 1

THE MALE PT RECEIVED A CYPHER SELECT STENT TO TREAT A BIFURCATED LESION IN THE LEFT CIRCUMFLEX AND THE FIRST OBTUSE MARGINAL. THE MAIN BRANCH IN THE FIRST OM HAD 80% STENOSIS AND THE SIDE BRANCH IN THE LCX HAD 80% STENOSIS. PT WAS TREATED WITH PROVISIONAL T STENTING. MAIN BRANCH WAS PREDILATED WITH A 2.25 X 12MM BALLOON AT 10 ATM A 2.5X13 MM CYPHER SELECT STENT WAS IMPLANTED AT 10ATM WITH NO POSTDILATATION. KISSING BALLOON 2.25 X 12MM (10ATM) WAS PERFORMED. FINAL STENOSIS WAS 0%. SIDE BRANCH WAS PREDILATED WITH A 2.25 X 12 BALLOON AT 16 ATM. NO POSTDILATATION WAS CONDUCTED. KISSING BALLOON 2.25 X 12MM (16 ATM) WAS CONDUCTED. FINAL STENOSIS WAS 0%. APPROXIMATELY EIGHT MONTHS POST-PROCEDURE, THE PT HAD A RE-PTCA OF THE TARGET LESION. PT HAD 90% RESTENOSIS IN THE MAIN BRANCH AND 30% OCCLUSION IN THE SIDE BRANCH. LESION WAS TREATED WITH BALLOON ANGIOPLASTY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DRUG-ELUTING STENT (NIQ) NIQ CORDIS DE MEXICO NA I0405107

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| R